Publications by authors named "Lisa Richards"

Claim this Profile
C
Clinical utility of phosphatidylethanol to detect underreported alcohol use and enhance steatotic liver disease subclassification.
Federica Tavaglione, Luis Antonio Díaz, Veeral Ajmera, Egbert Madamba, Seema Singh, Lisa Richards

J Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High inherited risk predicts age-associated increases in fibrosis in patients with MASLD.
Luis Antonio Díaz, William Alazawi, Saaket Agrawal, Juan Pablo Arab, Marco Arrese, Lisa M Richards

J Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Kaleb Tesfai, Luis Antonio Díaz, Juan Pablo Arab, Marco Arrese, Francisco Idalsoaga, Lisa M Richards

Aliment Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in screening and risk stratification for Hispanic adults with metabolic dysfunction-associated steatotic liver disease.
Monica A Tincopa, Luis Antonio Díaz, Daniel Q Huang, Juan Pablo Arab, Marco Arrese, Lisa Richards

Hepatology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive pathway for stratifying fibrosis in suspected metabolic dysfunction and alcohol-associated liver disease (MetALD).
Luis Antonio Díaz, Federica Tavaglione, Nikita Mittal, Ricki Bettencourt, Maral Amangurbanova, Lisa Richards

Hepatol Commun· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsy.
Rohit Loomba, Peter Chen-Yang Nikhil Daniel, Maral Amangurbanova, Ricki Bettencourt, Egbert Madamba, Lisa Richards

Hepatology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focused Recommendations for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH) by Advanced Practice Providers in the United States.
Brian P Lam, Jessica Bartholomew, Sherona Bau, HoChong Gilles, Andrea Keller, Lisa Richards

J Clin Gastroenterol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver Disease.
Luis Antonio Diaz, Sheldon Morris, Shravan Dave, Susy M Kim, Wathnita Sarik, Lisa Richards

Aliment Pharmacol Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-Head Comparison Between Phosphatidylethanol Versus Indirect Alcohol Biomarkers for Diagnosis of MetALD Versus MASLD: A Prospective Study.
Federica Tavaglione, Maral Amangurbanova, Alexander H Yang, Monica A Tincopa, Veeral Ajmera, Lisa Richards

Aliment Pharmacol Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA.
Alexander H Yang, Monica A Tincopa, Federica Tavaglione, Veeral H Ajmera, Lisa M Richards

Gut· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes.
Lana Bridi, Saaket Agrawal, Kaleb Tesfai, Egbert Madamba, Ricki Bettencourt, Lisa M Richards

Aliment Pharmacol Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH.
Rohit Loomba, Maral Amangurbanova, Ricki Bettencourt, Egbert Madamba, Harris Siddiqi, Lisa Richards

Gut· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study on the prevalence of at-risk MASH in patients with type 2 diabetes mellitus in the United States.
Nikita Mittal, Harris Siddiqi, Egbert Madamba, Lisa Richards, Ricki Bettencourt

Aliment Pharmacol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes.
Veeral Ajmera, Kaleb Tesfai, Erick Sandoval, Scarlett Lopez, Vanessa Cervantes, Lisa Richards

Hepatology· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter Study.
Daniel Q Huang, Noora Ahlholm, Panu K Luukkonen, Kimmo Porthan, Maral Amangurbanova, Lisa Richards

Clin Gastroenterol Hepatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Daniel Q Huang, Veeral Ajmera, Christian Tomaszewski, Andrew LaFree, Ricki Bettencourt, Lisa Richards

Adv Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD.
Beom K Kim, Nicole Bernstein, Daniel Q Huang, Nobuharu Tamaki, Kento Imajo, Lisa Richards

Aliment Pharmacol Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes.
Veeral Ajmera, Sandra Cepin, Kaleb Tesfai, Heather Hofflich, Karen Cadman, Lisa Richards

J Hepatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using pressure-driven flow systems to evaluate laser speckle contrast imaging.
Colin T Sullender, Adam Santorelli, Lisa M Richards, Pawan K Mannava, Christopher Smith

J Biomed Opt· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD.
Beom Kyung Kim, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Lisa Richards

J Hepatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease.
Nobuharu Tamaki, Noora Ahlholm, Panu K Luukkonen, Kimmo Porthan, Suzanne R Sharpton, Lisa Richards

J Clin Invest· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of isoflurane-induced vasodilation and blood flow of cerebral vasculature revealed by multi-exposure speckle imaging.
Colin T Sullender, Lisa M Richards, Fei He, Lan Luan, Andrew K Dunn

J Neurosci Methods· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoting gender equity in very young adolescents: targeting a window of opportunity for social emotional learning and identity development.
Megan Cherewick, Sarah Lebu, Christine Su, Lisa Richards, Prosper F Njau

BMC Public Health· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography.
Veeral Ajmera, Amy Liu, Ricki Bettencourt, Debanjan Dhar, Lisa Richards

Aliment Pharmacol Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19.
Veeral Ajmera, Wesley K Thompson, Davey M Smith, Atul Malhotra, Ravindra L Mehta, Lisa Richards

Contemp Clin Trials· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis